RecruitingNot ApplicableNCT04791098

Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital


Sponsor

University Hospital, Clermont-Ferrand

Enrollment

150 participants

Start Date

Sep 16, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Solid-organ transplant patients are at increased risk of infectious diseases. Among this population, infectious diseases may be life-threatening or lead to graft rejection. Their prevention is an important challenge. Despite specific national recommendations, vaccination is underutilized. That is why we propose a dedicated infectious diseases consultation during pre-kidney transplantation assessment.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patient over 18
  • On the waiting list for kidney transplantation at Clermont-Ferrand
  • Free and informed consent
  • Affiliation to a social security system

Exclusion Criteria5

  • Patient under 18
  • Protected adults (individuals under guardianship by court order
  • Pregnant and nursing women
  • Prior graft (solid organs or hematopoietic stem cells)
  • Absence of consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSpecific infectious diseases consultation

Specific infectious diseases consultation at Clermont Ferrand Hospital with a specialist doctor : * Update vaccinations * Advice to travelers * Diagnostic and treatment of latent tuberculosis infection


Locations(1)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04791098


Related Trials